Ambrx Inc. (acquired by Shanghai Fosun Pharmaceutical Group, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech)

Brief Description

Ambrx is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics using an expanded genetic code. Unlike conventional conjugation techniques that create a mixture of suboptimal molecules, Ambrx technology combines site specific conjugation with proprietary linkers, payloads and pharmacokinetic extenders to create a single molecular species that is optimized for safety, efficacy and biophysical properties. This process is called Protein Medicinal Chemistry.

Inventor

Tech Category

  • Medical Therapeutics

JOIN OUR NEWSLETTER